The EPS projection of T2 Biosystems, Inc. (NASDAQ:TTOO) for quarter ended 2016-09-30 is $-0.53. Last week, the projection for EPS was $-0.53 against target of $-0.53, a month earlier. While 2-months ago, this projection was $-0.53 versus forecast of $-0.53a quarter months earlier, posting a deviation of -0.01%.
T2 Biosystems, Inc. (NASDAQ:TTOO) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 1 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 1, and 2, correspondingly.
The per-share earnings downgrade for T2 Biosystems, Inc. (NASDAQ:TTOO) in the preceding 30 and 120 were 1 and 1. While in 60 and 90 days were 1, and 1, in that order.
T2 Biosystems, Inc. (NASDAQ:TTOO) EPS target was $-0.53 for the quarter closed 1. It was based on 3 calls. As on 2016-05-02 the EPS was $-0.55. The change was $0, posting a deviation of 0%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
T2 Biosystems, Inc. (NASDAQ:TTOO) sales prediction for the fiscal 2016 stands at $3.725 and the median estimate is at $3.725. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $4.45 while the lowest target is $3 showing standard deviation of 1.025%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -22.797%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...